General news

  • May 19th, 2021

Visite de Mathieu Michel, Secrétaire d’Etat à la Digitalisation

La société Radiomics est heureuse et fière d’annoncer la visite, ce 19 mai 2021, de Monsieur Mathieu Michel, Secrétaire d’Etat fédéral belge à la Digitalisation, chargé de la Simplification administrative, de la Protection de la vie privée et de la Régie des Bâtiments.

  • May 3rd, 2021

Radiomics Opens its first North American office in Toronto, Ontario

Radiomics is pleased to announce the official opening of its first North American sales and support office with the support of the Walloon investment support agency AWEX. The new office, established in Toronto, Ontario will kick-start the company's partnerships in the area, better accommodating pharma companies and clinicians’ needs through North America-based team members.

  • April 20th, 2021

Radiomics CEO Wim Vos guest at Tekna Talks

Wim Vos CEO of Radiomics guest at Tekna Talks: Drug discovery – from airflow around a bobsleigh to airflow in the lungs.

  • March 22nd, 2021

TIGER Consortium awarded EU Commission grant of EUR 6.9 million

The TIGER consortium led by eTheRNA immunotherapies and including Radiomics, is awarded an EU Commission’s grant for an HPV 16+ vaccine clinical trial

  • March 2nd, 2021

DRAGON: la IA contro il COVID-19

L’Europa ha lanciato un nuovo progetto chiamato Dragon, per applicare l’intelligenza artificiale alla battaglia contro il COVID-19.

  • February 22nd, 2021

Artsen pakken problemen binnenoor aan met artificial intelligence

Wetenschappers van het Maastricht UMC+, de Universiteit Maastricht, het Universitair Ziekenhuis Antwerpen (UZA), de Universiteit Antwerpen hebben samen met de Belgische startup Radiomics een nieuwe methode ontwikkeld om het binnenoor te onderzoeken. Hiervoor maken zij gebruik van artificial intelligence (AI).

  • February 22nd, 2021

Binnenoor beter herkennen met kunstmatige intelligentie

De Belgische startup Radiomics heeft een nieuwe, op kunstmatige intelligentie gebaseerde, methode ontwikkeld om het binnenoor beter en nauwkeuriger in kaart te brengen tijdens een MRI-onderzoek. Een actie die nu nog handmatig uitgevoerd wordt door artsen. Bij de ontwikkeling heeft Radiomics nauw samengewerkt met artsen en wetenschappers van het Maastricht UMC+ (MUMC+), de Universiteit Maastricht, het Universitair Ziekenhuis Antwerpen (UZA) en de Universiteit Antwerpen.

  • February 22nd, 2021

Kunstmatige intelligentie vereenvoudigt onderzoek binnenoor

Artsen en wetenschappers van onder meer het Maastricht UMC+ en de Universiteit Maastricht hebben een methode ontwikkeld om het binnenoor in kaart te brengen met behulp van kunstmatige intelligentie.

  • February 22nd, 2021

Artificial intelligence helps doctors address inner ear problems

A new method to map the inner ear using artificial intelligence (AI). That is what the Belgian start-up Radiomics has developed in close collaboration with doctors and scientists from Maastricht UMC +, Maastricht University, Antwerp University Hospital (UZA) and the University of Antwerp.

  • February 18th, 2021

AI tool for the segmentation of the inner ear on MRI

Radiomics together with UZAntwerpen and UMaastricht, has developed a novel tool for the automatic identification of the inner ear on MRI

  • January 26th, 2021

OncoRadiomics becomes Radiomics

With great enthusiasm and pride, the OncoRadiomics team today unveils the company's new brand identity: ‘Radiomics’.

  • January 26th, 2021

La start-up liégeoise OncoRadiomics change de nom

OncoRadiomics, la pépite liégeoise spécialisée dans l'intelligence artificielle appliquée à l'imagerie dans le secteur de la santé, devient Radiomics.

  • January 26th, 2021

Radiomics un nouveau nom et des objectifs de croissance

OncoRadiomics, spin-off de l’Université de Maastricht installée à Liège et spécialisée dans le développement d’outils innovants de radiométrie, devient Radiomics afin que cette nouvelle identité corresponde davantage à ses projets de développement et ses objectifs de croissance.

  • January 4th, 2021

Carlos Meca joins Radiomics as CCO

Radiomics is glad to start the new year 2021 announcing and welcoming its new Chief Commercial Officer (CCO) Carlos Contreras Meca!

  • December 30th, 2020

Radiomic CT Signature for Detecting COVID-19

Radiomics developed a fully automated AI framework to extract radiomics features to classify COVID-19 infected patients from standard-of-care medical images (CT).

  • November 30th, 2020

ESTRO 2020

Presentation of our work on the prospective validation of a radiomics signature for chemoradiotherapy lung cancer patients

  • October 30th, 2020

The DRAGON project: fighting Coronavirus pandemics

The DRAGON project led by Radiomics in partnership with 18 high-tech SMEs, academic research institutes, biotech and pharma partners, affiliated patient-centred organisations and professional societies from Belgium, Italy, the Netherlands, Switzerland and the UK, has been selected for funding by the Innovative Medicines Initiative (IMI), with an evaluation score placing it in the 95% percentile.

  • October 1st, 2020

Mariaelena Occhipinti joins Radiomics as CMO

Radiomics is glad to welcome its new Chief Medical Officer, Mariaelena Occhipinti!